- Home
- LDI vs NBTX Comparison
LDI vs NBTX Comparison
Compare LDI & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDI
- NBTX
- Stock Information
- Founded
- LDI 2010
- NBTX 2003
- Country
- LDI United States
- NBTX France
- Employees
- LDI N/A
- NBTX N/A
- Industry
- LDI Finance: Consumer Services
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- LDI Finance
- NBTX Health Care
- Exchange
- LDI Nasdaq
- NBTX Nasdaq
- Market Cap
- LDI 954.8M
- NBTX 868.8M
- IPO Year
- LDI 2021
- NBTX 2020
- Fundamental
- Price
- LDI $2.91
- NBTX $21.04
- Analyst Decision
- LDI Sell
- NBTX Strong Buy
- Analyst Count
- LDI 3
- NBTX 1
- Target Price
- LDI $2.30
- NBTX $8.00
- AVG Volume (30 Days)
- LDI 16.0M
- NBTX 112.7K
- Earning Date
- LDI 11-04-2025
- NBTX 09-30-2025
- Dividend Yield
- LDI N/A
- NBTX N/A
- EPS Growth
- LDI N/A
- NBTX N/A
- EPS
- LDI N/A
- NBTX N/A
- Revenue
- LDI $1,124,074,000.00
- NBTX $11,930,711.00
- Revenue This Year
- LDI $19.82
- NBTX N/A
- Revenue Next Year
- LDI $17.78
- NBTX $74.67
- P/E Ratio
- LDI N/A
- NBTX N/A
- Revenue Growth
- LDI 27.06
- NBTX N/A
- 52 Week Low
- LDI $1.01
- NBTX $2.76
- 52 Week High
- LDI $5.05
- NBTX $22.51
- Technical
- Relative Strength Index (RSI)
- LDI 48.66
- NBTX 71.69
- Support Level
- LDI $2.87
- NBTX $19.11
- Resistance Level
- LDI $3.14
- NBTX $22.64
- Average True Range (ATR)
- LDI 0.29
- NBTX 1.64
- MACD
- LDI -0.12
- NBTX 0.63
- Stochastic Oscillator
- LDI 2.68
- NBTX 83.03
About LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.